1) Association among weight change, glycemic control, and markers of cardiovascular risk with exenatide once weekly: a pooled analysis of patients with type 2 diabetes Lawrence Blonde1*, Richard Pencek2 and Leigh MacConell2 Conclusions Exenatide once weekly improved glycemic parameters independent of weight change, although the magnitude of improvement increased with increasing weight loss. The greatest trend of improvement in glycemic parameters, cardiovascular risk factors including systolic BP, LDL-C, total cholesterol, and triglycerides, and in liver enzymes, was seen in the patient quartiles with the greatest reductions in body weight.
2) The effect of clopidogrel on platelet activity in patients with and without type-2 diabetes mellitus: a comparative study Claudia Schuette†, Daniel Steffens†, Marco Witkowski, Caroline Stellbaum, Peter Bobbert,Heinz-Peter Schultheiss and Ursula…
